Alejandro Bernal - Zoetis President

<div class='logoBackup' style='background:#2A0CD0;color: white;font-size:3em;;'>ZTS</div>
ZTS -- USA Stock  

0.2 Dividend

Mr. Alejandro Bernal is Executive Vice President, Group President Strategy, Commercial and Business Development of Zoetis Inc. From October 2012 through April 2015 he served as our Executive Vice President and Area President of the Europe, Africa and Middle East region. He was Area President of the Europe, Africa and Middle East region for Pfizers animal health business unit from 2010 to 2012
Age: 43  President Since 2015  MBA    
973 822-7000
Bernal joined Pfizer in 2000 and held various positions, including Area President of the Canada and Latin America region; Regional Director of Southwest and Central Latin America; Division Director for Central America and Colombia; Swine and Poultry Team Leader for Mexico; and Swine Product Manager for Northern Latin America for Pfizer Animal Health. Alejandro holds a doctorate in veterinary medicine from Universidad de Caldas, a master degree in physiology from Texas A&M University, and a MBA from Universidad de los Andes and Manchester Business School .

Alejandro Bernal Latest Insider Activity

Management Efficiency

The company has 6.66 B in debt with debt to equity (D/E) ratio of 248.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


K RaoDr Reddys Laboratories Ltd
John HendricksonPerrigo Company Plc
Jay MarkowitzRegeneron Pharmaceuticals
Paul WeningerPerrigo Company Plc
Alok SonigDr Reddys Laboratories Ltd
J RamachandranDr Reddys Laboratories Ltd
Charles MilsteinVertex Pharmaceuticals Incorpor
Michael StewartPerrigo Company Plc
Christopher FenimoreRegeneron Pharmaceuticals
Daniel PlewRegeneron Pharmaceuticals
Amit SachdevVertex Pharmaceuticals Incorpor
Amit BiswasDr Reddys Laboratories Ltd
Grainne QuinnPerrigo Company Plc
Jeffrey NeedhamPerrigo Company Plc
Paul SilvaVertex Pharmaceuticals Incorpor
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Scott JamisonPerrigo Company Plc
Samiran DasDr Reddys Laboratories Ltd
Jatin ShahPerrigo Company Plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Umang VohraDr Reddys Laboratories Ltd

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Did you try this?

Run Money Managers Now


Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Also Currentnly Active

Sold over 100K shares of
3 days ago
Traded for 0.175
Purchased over 10K shares of
3 days ago
Traded for 2.5
Purchased over 100 shares of
3 days ago
Traded for 15.49
See also Your Current Watchlist. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.